CK7 antibodies are monoclonal immunoglobulins designed to detect Cytokeratin 7, a 55 kDa protein encoded by the KRT7 gene. These antibodies are widely used to identify epithelial origin in tumors and study cellular differentiation .
Host Species: Rabbit (e.g., clone EPR17078) or mouse (e.g., clones OV-TL 12/30, KRT7/760 + KRT7/903) .
Specificity: Validated using knockout cell lines and peptide absorption .
Applications: Western blot (WB), immunohistochemistry (IHC), immunocytochemistry (ICC), flow cytometry, and immunofluorescence (IF) .
CK7 antibodies are optimized for diverse methodologies:
The BC1 rabbit monoclonal antibody demonstrates superior intensity and debris staining compared to the mouse OV-TL 12/30 clone .
CK7 expression patterns aid in tumor classification and prognosis:
CK7 regulates HPV16 E7 mRNA translation and interferon-dependent cell cycle arrest .
In CRC, CK7+ tumors exhibit dedifferentiation markers and aggressive budding phenotypes .
Multiplex Staining: CK7/CDX2/TTF1 cocktails enable simultaneous detection of multiple biomarkers in lung and gastrointestinal cancers .
Cross-Reactivity: Rabbit monoclonal antibodies show broader species reactivity (human, mouse, rat) vs. mouse clones (human-specific) .
Specificity Checks: Knockout cell lines (e.g., KRT7–/–) confirm absence of off-target binding .
Reproducibility: Affinity purification via Protein A/G ensures >90% purity .